Immunomedics Announces First Quarter Fiscal 2016 Results and Clinical Program Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. NVDA
4. AWK
5. TSLA
6. GNK
7. USO
8. ARGX
9. SPCX
10. AZN

Go back to Immunomedics Announces First Quarter Fiscal 2016 Results and Clinical Program Developments

Immunomedics (IMMU) Misses Q1 EPS by 2c

November 5, 2015 8:51 AM EST

Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Immunomedics (IMMU) click here.

... More